Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Head & Neck 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Solid Tumors 4Stomach Neoplasms 1Pancreatic Neoplasms 1Nasopharyngeal Neoplasms 1Mesothelioma 1Liver Neoplasms 1Kidney Neoplasms 1Immune-related Adverse Events 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

pembrolizumab 9Hyperthermic Intraperitoneal Chemotherapy 3fludarabine 2budigalimab 2Nivolumab 2Ipilimumab 2Cytoreduction Surgical Procedures 2Cyclophosphamide 2Cisplatin 2venetoclax 1tocilizumab 1tislelizumab 1talazoparib 1spartalizumab 1sodium thiosulfate 1rovalpituzumab tesirine 1regorafenib 1milademetan 1irinotecan sucrosofate 1fludarabine phosphate 1epacadostat 1entinostat 1atezolizumab 1X-Rays 1Surgical Procedures, Operative 1Specimen Handling 1Sirolimus 1Quality of Life 1Polymerase Chain Reaction 1Platinum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × tocilizumab × Other solid neoplasm × Clear all
NCT05070247 2026-01-22

A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

Takeda

Phase 1/2 Terminated
61 enrolled 29 charts
BreastGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Kidney Neoplasms, Liver Neoplasms, Mesothelioma, Nasopharyngeal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡